UNSPSC 85311900: Diagnoses of rheumatic tricuspid valve diseases

This classification denotes the group of activities that yields a diagnosis of Rheumatic Tricuspid Valve Diseases.

Rheumatic Tricuspid Valve Diseases is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems or Icd-10 as a Three Digit Category under code A00 Icd-10 Also Has The Following Rheumatic Tricuspid Valve Diseases Children in its Four-Character Category: I070 or Tricuspid Stenosis; I071 or Tricuspid Insufficiency; I072 or Tricuspid Stenosis With Insufficiency; I078 or Other Tricuspid Valve Diseases; I079 or Tricuspid Valve Disease, Unspecified RHEUMATIC TRICUSPID VALVE DISEASES is listed in the Centers For Medicare & Medicaid Services International Classification Of Diseases Clinical Modification (Tenth Revision) (Icd-10-CM) as a Three Digit Category under code I07.

UNSPSC 85311900 Diagnoses of rheumatic tricuspid valve diseases is a Class code with minimal recent state and local procurement activity directly aligned to its nominal scope. The single recent opportunity posted under this code—San Mateo Medical Center's Diagnostic Imaging PACS (Picture Archiving and Communication System) solicitation—addresses diagnostic imaging infrastructure and system integration rather than the clinical diagnosis or treatment of rheumatic valve disease. The other two opportunities in the recent block (Birdville Independent School District's special education contracted services and Santa Clara County Health System's temporary health professional staffing) show no connection to the code's stated category and appear to be misclassified. This code sees little to no active state and local procurement volume for the clinical services it nominally describes.

The source provides no evidence of sustained state and local purchasing for diagnoses of rheumatic tricuspid valve diseases or related diagnostic protocols under this code. State and local health systems, school districts, and public health authorities do not appear to be actively soliciting this specialized clinical diagnostic service through open competitive procurement channels. Business development teams evaluating this code should monitor for future activity but should not expect material opportunity flow in the near term based on current market signals.